Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.49%
#3 Fake World Assets Fake World Assets +8.26%
#4 Perle Perle +3.98%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +3.72%
#6 Dual Dual +3.58%
#7 Casper Network Casper Network +3.58%
#8 Figure Heloc Figure Heloc +3.49%
#9 Movement Movement +3.23%
#10 Orochi Network Orochi Network +3.13%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ra Medical Systems, Inc. Ra Medical Systems, Inc.

Ra Medical Systems, Inc.

RMED
Rang in Aktien #38063
Ra Medical Systems, Inc. operates as a medical technology enterprise... Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.
Aktienkurs
$0.575
Zuletzt synchronisiert: 2023-09-15
Marktkapitalisierung
$1.24M
Veränderung (1 Tag)
9.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Ra Medical Systems, Inc. (RMED)

Kategorie

Healthcare
P/S-Verhältnis für Ra Medical Systems, Inc. (RMED)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Ra Medical Systems, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Ra Medical Systems, Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
3.95 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.83 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.31 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
7.61 -
US